RxDoctor Payments Data

Rodrick Heger

Emergency Medicine · Hugoton, KSNPI 1932134194

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AstraZeneca at 43.4% of the total. Among emergency medicine clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$477in general payments, 2019–2025

Across 27 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$207
  • Medtronic$56
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$45
  • Lilly USA, LLC$42
  • Amgen$34
  • Merck$28
  • plus $65 from 4 others

What the payments were for

  • Food & beverage$46397%
  • Education$143%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$477 in reported general payments places this provider in the 90th percentile of 334 emergency medicine providers in Kansas.

See all emergency medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$3,439
Medicare patients
28
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban59$32,427
JardianceEmpagliflozin29$27,481
FarxigaDapagliflozin Propanediol42$26,184
TradjentaLinagliptin33$25,159
TrulicityDulaglutide24$23,289
XareltoRivaroxaban30$17,377
JanuviaSitagliptin Phosphate23$15,542
OzempicSemaglutide13$12,339
Tresiba Flextouch U-100Insulin Degludec13$11,228
JanumetSitagliptin Phos/Metformin Hcl14$10,049
BelsomraSuvorexant12$5,411
MyrbetriqMirabegron13$5,148
Novolog FlexpenInsulin Aspart18$4,173
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$2,052
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc20$2,029

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet, Belsomra$28$31,00349 claims
AstraZenecaFarxiga$207$26,18442 claims
Lilly USA, LLCTrulicity$42$23,28924 claims
Novo NordiskOzempic$17$12,33913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 334 emergency medicine providers in Kansas.

Other emergency medicine in Hugoton

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →